• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用正电子发射断层显像(PET)评估治疗反应。

Assessment of treatment response using PET.

作者信息

Basu Sandip, Kumar Rakesh, Ranade Rohit

机构信息

Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Jerbai Wadia Road, Parel, Mumbai 400012, India.

Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

PET Clin. 2015 Jan;10(1):9-26. doi: 10.1016/j.cpet.2014.09.002. Epub 2014 Oct 14.

DOI:10.1016/j.cpet.2014.09.002
PMID:25455877
Abstract

This article reviews the major treatment response evaluation guidelines in the domain of cancer imaging and how the potential of PET imaging, particularly with fluorodeoxyglucose, is increasingly explored in this important aspect of cancer management. Certain disease-specific response criteria (such as in lymphoma) are also reviewed with emphasis on the changes made over time and the main areas of concern in PET interpretation. The major present clinical applications are illustrated and potential new areas are discussed with regard to clinical applications in the future. Finally, the evolving role of newer and novel PET metrics, which hold promise in treatment response evaluation, is illustrated with examples.

摘要

本文回顾了癌症影像学领域主要的治疗反应评估指南,以及在癌症管理这一重要方面,正如何越来越多地探索正电子发射断层显像(PET)成像的潜力,尤其是使用氟脱氧葡萄糖的PET成像。还对某些特定疾病的反应标准(如淋巴瘤的反应标准)进行了回顾,重点是随着时间推移所做的改变以及PET解读中主要关注的领域。文中说明了目前主要的临床应用,并讨论了未来临床应用方面潜在的新领域。最后,通过实例说明了在治疗反应评估方面有望发挥作用的更新颖的PET指标不断演变的作用。

相似文献

1
Assessment of treatment response using PET.使用正电子发射断层显像(PET)评估治疗反应。
PET Clin. 2015 Jan;10(1):9-26. doi: 10.1016/j.cpet.2014.09.002. Epub 2014 Oct 14.
2
An update on novel quantitative techniques in the context of evolving whole-body PET imaging.在不断发展的全身正电子发射断层显像(PET)成像背景下新型定量技术的最新进展。
PET Clin. 2015 Jan;10(1):45-58. doi: 10.1016/j.cpet.2014.09.004. Epub 2014 Nov 22.
3
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.EORTC 标准与 PERCIST 标准在评估接受伊立替康和西妥昔单抗治疗的转移性结直肠癌患者 PET/CT 疗效中的比较。
J Nucl Med. 2013 Jul;54(7):1026-31. doi: 10.2967/jnumed.112.111757. Epub 2013 Apr 9.
4
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.使用参数成像技术检测和描述 18F-FDG PET 患者监测中的肿瘤变化。
J Nucl Med. 2011 Mar;52(3):354-61. doi: 10.2967/jnumed.110.080150.
5
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.从RECIST到PERCIST:实体瘤中PET反应标准的不断演变的考量
J Nucl Med. 2009 May;50 Suppl 1(Suppl 1):122S-50S. doi: 10.2967/jnumed.108.057307.
6
Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments.使用氟代脱氧葡萄糖正电子发射断层扫描评估肿瘤反应:实体瘤疗效评价标准的更新、与欧洲癌症研究与治疗组织标准的比较以及未来发展线索
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):55-66. doi: 10.1007/s00259-017-3687-3. Epub 2017 Mar 30.
7
Molecular imaging (PET) of brain tumors.脑肿瘤的分子影像学(PET)。
Neuroimaging Clin N Am. 2009 Nov;19(4):625-46. doi: 10.1016/j.nic.2009.08.012.
8
Quantification in clinical fluorodeoxyglucose positron emission tomography.临床氟脱氧葡萄糖正电子发射断层扫描中的定量分析。
Nucl Med Commun. 2004 Jul;25(7):647-50. doi: 10.1097/01.mnm.0000134327.85170.6b.
9
Positron emission tomography/computed tomography: the current technology and applications.正电子发射断层扫描/计算机断层扫描:当前技术与应用
Radiol Clin North Am. 2009 Jan;47(1):147-60. doi: 10.1016/j.rcl.2008.10.005.
10
Standards for PET image acquisition and quantitative data analysis.PET图像采集与定量数据分析标准。
J Nucl Med. 2009 May;50 Suppl 1:11S-20S. doi: 10.2967/jnumed.108.057182. Epub 2009 Apr 20.

引用本文的文献

1
Dual-Layer Spectral Detector Computed Tomography Quantitative Parameters: A Potential Tool for Lymph Node Activity Determination in Lymphoma Patients.双层光谱探测器计算机断层扫描定量参数:淋巴瘤患者淋巴结活性测定的潜在工具。
Diagnostics (Basel). 2024 Jan 9;14(2):149. doi: 10.3390/diagnostics14020149.
2
PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.基于 PET/CT 的癌症疗效评估——设计问题的系统综述。
Mol Imaging Biol. 2020 Feb;22(1):33-46. doi: 10.1007/s11307-019-01351-4.
3
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.
头颈部PET/CT治疗反应解读标准(霍普金斯标准)——外部验证研究
Am J Nucl Med Mol Imaging. 2017 Sep 1;7(4):174-180. eCollection 2017.
4
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.[11C]胆碱正电子发射断层显像/计算机断层扫描在局部晚期高危前列腺癌根治性前列腺切除术前行新辅助治疗疗效评估中的应用
Oncotarget. 2016 Sep 27;7(39):63747-63757. doi: 10.18632/oncotarget.11653.
5
Prospective evaluation of [C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.[C]胆碱正电子发射断层显像/计算机断层扫描(PET/CT)对晚期去势抵抗性前列腺癌患者标准化多西他赛一线化疗疗效评估的前瞻性研究
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2105-2113. doi: 10.1007/s00259-016-3439-9. Epub 2016 Jun 17.
6
Imaging Biomarkers in Immunotherapy.免疫治疗中的影像生物标志物
Biomark Cancer. 2016 Feb 25;8(Suppl 2):1-13. doi: 10.4137/BIC.S31805. eCollection 2016.
7
PET-CT in the sub-arctic region of Norway 2010-2013. At the edge of what is possible?2010 - 2013年挪威亚北极地区的正电子发射断层显像/X线计算机体层成像(PET - CT)。处在可行范围的边缘?
BMC Med Imaging. 2015 Aug 28;15:36. doi: 10.1186/s12880-015-0073-0.